Skip to main content
Have a personal or library account? Click to login
Axonal Degeneration and Neuropathy Target Esterase Cover
By:   
Open Access
|Oct 2007

References

  1. Cavanagh JB. The significance of the "dying back" process in experimental and human neurological disease.1964;3:219-67.
  2. Ehrich M, Jortner BS. Organophosphorus-induced delayed neuropathy. In: Krieger R, editor.Vol. 2. 2ed. San Diego (CA): Academic Press; 2001 . p. 987-1012.
  3. Johnson MK. The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications.1982;4:141-212.
  4. Lotti M. Organophosphorus compounds. In: Spencer PS, Schaumburg HH, Ludolph AC, editors. Experimental and Clinical Neurotoxicology. 2ed. New York (USA): Oxford University Press; 2000. p. 897-925.
  5. Lush MJ, Li Y, Read DJ, Willis AC, Glynn P. Neuropathy target esterase and a homologous Drosophila neurodegeneration associated mutant protein contain a novel domain conserved from bacteria to man.1998;332:1-4.
  6. Li Y, Dinsdale D, Glynn P. Protein domains, catalytic activity and subcellular distribution of neuropathy target esterase in mammalian cells.2003;278:8820-5.
  7. Zaccheo O, Dinsdale D, Meacock PA, Glynn P. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells.2004;279:24024-33.
  8. Mühlig-Versen M, Bettencourt da Cruz A, Tschäpe J-A, Moser M, Büttner R, Athenstaedt K, Glynn P, Kretzschmar D. Loss of Swiss cheese/Neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila.2005;25:2865-73.
  9. Akassoglou K, Malester B, Xu J, Tessarollo L, Rosenbluth J, Chao M. Brain-specific deletion of neuropathy target esterase/swiss cheese results in neurodegeneration.2004;101:5075-80.
  10. Veronesi B, Padilla S, Blackmon K, Pope C. Murine susceptibility to organophosphorus-induced delayed neuropathy.1991;107:311-24.
  11. Lapadula DM, Patton SE, Campbell GA, Abou-Donia MB. Characterisation of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate1985;79:83-90.
  12. Johnson MK, Lauwerys R. Protection by some carbamates against the delayed neurotoxic effects of di-isopropyl phosphorofluoridate.1969;222:1066-7.
  13. Johnson MK. The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters.1974;23:785-9.
  14. Johnson MK. Organophosphates and delayed neuropathy-is NTE alive and well?1990;102:385-99.
  15. Glynn P. Neural development and neurodegeneration: two faces of neuropathy target esterase.2000;61:61-74.
  16. Lotti M. The pathogenesis of organophosphate polyneuropathy.1992;21:465-87.
  17. Moretto A, Lotti M, Sabri MI, Spencer PS. Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy.1987;49:1515-22.
  18. Kretzschmar D, Hasan G, Sharma S, Heisenberg M, Benzer S. The swisscheese mutant causes glial hyperwrapping and brain degeneration in Drosophila.1997;17:7425-32.
DOI: https://doi.org/10.2478/v10004-007-0029-z | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English, Croatian
Page range: 355 - 358
Published on: Oct 9, 2007
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services

© 2007 Paul Glynn, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.